BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32047232)

  • 1. A novel next generation sequencing approach to improve sarcoma diagnosis.
    McConnell L; Houghton O; Stewart P; Gazdova J; Srivastava S; Kim C; Catherwood M; Strobl A; Flanagan AM; Oniscu A; Kroeze LI; Groenen P; Taniere P; Salto-Tellez M; Gonzalez D
    Mod Pathol; 2020 Jul; 33(7):1350-1359. PubMed ID: 32047232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of fusion transcripts in sarcoma from archival formalin-fixed paraffin-embedded tissues: A next-generation sequencing approach.
    Fujii T; Takeda M; Uchiyama T; Nitta Y; Maebou K; Terada C; Okada F; Matsuoka M; Sugimoto S; Sasaki S; Morita K; Itami H; Miyake M; Takeda M; Sawabata N; Fujimoto K; Ohbayashi C
    Pathol Int; 2022 Sep; 72(9):444-456. PubMed ID: 35975909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers.
    Niu D; Li L; Yu Y; Zang W; Li Z; Zhou L; Jia L; Rao G; Gao L; Cheng G; Ji K; Lin D
    Pathol Oncol Res; 2020 Oct; 26(4):2577-2585. PubMed ID: 32621174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy of Molecular Analysis in the Diagnosis of Bone and Soft Tissue Sarcoma: A 15-Year Mono-Institutional Study.
    Benini S; Gamberi G; Cocchi S; Magagnoli G; Fortunato AR; Sciulli E; Righi A; Gambarotti M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities.
    van de Rijn M; Guo X; Sweeney RT; Beck AH; West RB
    Histopathology; 2014 Jan; 64(1):163-70. PubMed ID: 24107169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
    Szurian K; Kashofer K; Liegl-Atzwanger B
    Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of salivary gland and sinonasal fusions by a next-generation sequencing based, ligation-dependent, multiplex RT-PCR assay.
    Lanic MD; Guérin R; Wassef M; Durdilly P; Rainville V; Sater V; Jardin F; Ruminy P; Costes-Martineau V; Laé M
    Histopathology; 2023 Nov; 83(5):685-699. PubMed ID: 37350081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay.
    Lanic MD; Le Loarer F; Rainville V; Sater V; Viennot M; Beaussire L; Viailly PJ; Angot E; Hostein I; Jardin F; Ruminy P; Laé M
    Mod Pathol; 2022 May; 35(5):649-663. PubMed ID: 35075283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
    Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V
    Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.
    Steeghs EMP; Kroeze LI; Tops BBJ; van Kempen LC; Ter Elst A; Kastner-van Raaij AWM; Hendriks-Cornelissen SJB; Hermsen MJW; Jansen EAM; Nederlof PM; Schuuring E; Ligtenberg MJL; Eijkelenboom A
    BMC Cancer; 2020 Apr; 20(1):291. PubMed ID: 32264863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Would Next Generation Sequencing Bring to the Diagnosis and Treatment of Sarcomas? A Series of 20 Cases, a Single Institution's Experience.
    Kulaç İ; Bulutay P; Meriçöz ÇA
    Turk Patoloji Derg; 2021; 37(3):226-232. PubMed ID: 34514574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases.
    Mantilla JG; Ricciotti RW; Chen E; Hoch BL; Liu YJ
    Genes Chromosomes Cancer; 2019 Oct; 58(10):713-722. PubMed ID: 31033080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel fusion sarcomas including targetable NTRK and ALK.
    Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
    Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
    Haley L; Parimi V; Jiang L; Pallavajjala A; Hardy M; Yonescu R; Morsberger L; Stinnett V; Long P; Zou YS; Gocke CD
    J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
    Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
    Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.